Counselors in Natchez, LA Accepting Medicare
5 Counselors found. Showing 1 - 5
 Brenda Forest Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 213 Johnson Street, Natchez, LA 71456 Phone: 318-521-2550 |
Anna Forest Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 154 Johnson Lp., Natchez, LA 71456 Phone: 318-527-1152 |
Chriscella Metoyer Counselor Medicare: Not Enrolled in Medicare Practice Location: 2353 Highway 119, Natchez, LA 71456 Phone: 318-332-7609 |
Mrs. April Howell Matt, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 3924 Highway 494, Natchez, LA 71456 Phone: 318-352-8571 Fax: 318-352-8571 |
Tiffany Roque Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1462 Highway 484, Natchez, LA 71456 Phone: 318-554-8199 |
News Archive
Study finds widespread vitamin and mineral use among cancer survivors, although benefits of such use remain unclear
Use of vitamin and mineral supplements among cancer survivors is widespread, despite inconclusive evidence that such use is beneficial, according to a comprehensive review of scientific literature conducted by researchers at Fred Hutchinson Cancer Research Center and published Feb. 1 in the Journal of Clinical Oncology.
How does the antitumor drug get to the cell nucleus?
Platinum complexes such as the well-known cisplatin are powerful antitumor medications. They cross the cell membrane and reach the nucleus, where they attach to DNA and stop cell growth. But how does cisplatin get to the nucleus Italian researchers have now proven that a copper transport protein may play a critical role.
IFNa-kinoid shows promise against lupus
The first study to show results using active immunotherapy against the signaling protein interferon alpha in the treatment of lupus will be presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago.
TauRx initiates LMTX Phase 3 trial in Pick's Disease
TauRx Therapeutics today announced the initiation of a global Phase 3 clinical trial in a type of Frontotemporal Dementia (FTD) also known as Pick's Disease. The announcement, which immediately follows The 8th International Conference on Frontotemporal Dementias, held 5-7 September in Manchester, England, underscores the need for new treatments for this form of dementia that is similar to Alzheimer's Disease, except that it tends to damage different areas of the brain and affects people as early as 40 years old.
Researchers analyze toxicity, other health risks of electronic tobacco heating system
The project was implemented in accordance with the request of the Government of Russian Federation on the evaluation of non-medicinal nicotine products. The inter-agency research group was based at the Semashko National Scientific Research Institute of Public Health.
› Verified 3 days ago